Joseph Straight, MD
Sports Medicine · Newark, DENPI 1063547511
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (40.8%), travel and lodging and education — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Pacira Pharmaceuticals Incorporated at 33.9% of the total. Reporting peaked in 2022 at $2,252 and has fallen 91.5% since, to $191 in 2025.
Across 104 payments — averaging $54.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pacira Pharmaceuticals Incorporated$2K
- Arthrex$1K
- Amgen$634
- Pacira Therapeutics, Inc.$484
- Zynex Medical, Inc.$418
- Liberty Surgical Inc.$353
- plus $439 from 5 others
What the payments were for
- Travel & lodging$2,04136%
- Food & beverage$2,32441%
- Education$1,33323%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pacira Pharmaceuticals Incorporated | 14 | $1,932 |
| Arthrex | 5 | $1,437 |
| Amgen | 49 | $634 |
| Pacira Therapeutics, Inc. | 11 | $484 |
| Zynex Medical, Inc. | 2 | $418 |
| Liberty Surgical Inc. | 2 | $353 |
| Ferring Pharmaceuticals Inc. | 7 | $144 |
| Terumo BCT, Inc. | 3 | $133 |
| Johnson & Johnson | 9 | $131 |
| Stryker | 1 | $16 |
| Bioventus LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few sports medicine providers in Delawareto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 111 | $447 |
| Methylprednisolone | 36 | $228 |
| Ibuprofen | 23 | $179 |
| Naproxen | 16 | $142 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Newark
- Michael AxeNewark$120K
- Bradley BleyNewark$3K
- Evan CrainNewark$1K
- Craig SternbergNewark$131
- Geoffrey GustavsenNewark$16
- Matthew VoltzWilmington$831
- Arnold GlassmanWilmington$485
- Barry BakstWilmington$200
- Terrence TsuiDover$71
- Claire SheltonWilmington$53
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.